These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Regression of nephrotic syndrome with colchicine therapy secondary to amyloidosis with associated Castleman's disease. Paydas S; Gonlusen G; Sagliker Y Nephron; 1995; 71(4):463-4. PubMed ID: 8587630 [No Abstract] [Full Text] [Related]
25. Resolution of nephrotic syndrome and lack of progression of heroin-associated renal amyloidosis. Crowley S; Feinfeld DA; Janis R Am J Kidney Dis; 1989 Apr; 13(4):333-5. PubMed ID: 2705451 [TBL] [Abstract][Full Text] [Related]
26. Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review. Fayand A; Boutboul D; Galicier L; Kahn JE; Buob D; Boffa JJ; Cez A; Oksenhendler E; Grateau G; Ducharme-Bénard S; Georgin-Lavialle S Amyloid; 2019 Dec; 26(4):197-202. PubMed ID: 31364863 [No Abstract] [Full Text] [Related]
27. Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor. Agha I; Mahoney R; Beardslee M; Liapis H; Cowart RG; Juknevicius I Am J Kidney Dis; 2002 Aug; 40(2):411-5. PubMed ID: 12148117 [TBL] [Abstract][Full Text] [Related]
28. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease). Montoli A; Minola E; Stabile F; Grillo C; Radaelli L; Spanti D; Luccarelli E; Spata C; Minetti L Am J Nephrol; 1995; 15(2):142-6. PubMed ID: 7733151 [TBL] [Abstract][Full Text] [Related]
29. HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis. Nunes MB; Rotman S; Duss FR; Halfon M BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31911409 [TBL] [Abstract][Full Text] [Related]
30. [Primary systemic AL amyloidosis with remarkable calcification in the spleen]. Uchiyama K; Tsukada N; Miyazaki K; Abe Y; Sekine R; Nakagawa Y; Suzuki K Rinsho Ketsueki; 2014 Mar; 55(3):334-9. PubMed ID: 24681937 [TBL] [Abstract][Full Text] [Related]
31. [Chronic inflammation and AA amyloidosis]. Blank N; Schönland SO Dtsch Med Wochenschr; 2013 Sep; 138(37):1835-8. PubMed ID: 24006165 [TBL] [Abstract][Full Text] [Related]
32. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis. Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532 [TBL] [Abstract][Full Text] [Related]
33. Recovery of acute renal failure and nephrotic syndrome following autologous stem cell transplantation for primary (AL) amyloidosis. Snanoudj R; Mamzer-Bruneel MF; Hermine O; Grunfeld JP; Chauveau D Nephrol Dial Transplant; 2003 Oct; 18(10):2175-7. PubMed ID: 13679499 [No Abstract] [Full Text] [Related]
34. Membranous Nephropathy Associated With Multicentric Castleman Disease-Efficacy of Interleukin 6 Antibody for Nephrotic Syndrome. Horino T; Kashio T; Inotani S; Ishihara M; Ichii O J Clin Rheumatol; 2022 Jan; 28(1):e1-e2. PubMed ID: 34897198 [No Abstract] [Full Text] [Related]
35. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis. Leung N; Dispenzieri A; Fervenza FC; Lacy MQ; Villicana R; Cavalcante JL; Gertz MA Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045 [TBL] [Abstract][Full Text] [Related]
36. High dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis. Sanchorawala V Hematol Oncol Clin North Am; 2014 Dec; 28(6):1131-44. PubMed ID: 25459183 [TBL] [Abstract][Full Text] [Related]
37. [A 21-year-old male patient with nephrotic syndrome and "idiopathic" AA amyloidosis]. Saura IM; Carretón A; López Guillén E; Alegría MS; Jimeno García L; Ferri B Nefrologia; 2004; 24 Suppl 3():109-12. PubMed ID: 15219083 [TBL] [Abstract][Full Text] [Related]
38. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience. Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891 [TBL] [Abstract][Full Text] [Related]
39. AL amyloidosis with renal involvement. Rysavá R Kidney Blood Press Res; 2007; 30(6):359-64. PubMed ID: 17851224 [TBL] [Abstract][Full Text] [Related]
40. Chronic nephrotic syndrome and chronic renal failure by amyloidosis secondary to xanthogranulomatous pyelonephritis. Işlek I; Bariş S; Albayrak D; Büyükalpelli R; Sancak R Clin Nephrol; 1998 Jan; 49(1):62-5. PubMed ID: 9491290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]